venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $180,424 (100.0% shares, 0.0% debt)

Holdings (6)

VTYX VENTYX BIOSCIENCES INC 42.7%

Value ($000) $77,011 Shares 2,298,833 Est. Cost $18.95 Unrealized +105.2%

ALXO ALX ONCOLOGY HLDGS INC 24.3%

Value ($000) $43,844 Shares 9,699,925 Est. Cost $39.31 Unrealized -80.7%

HRMY HARMONY BIOSCIENCES HLDGS IN 18.7%

Value ($000) $33,806 Shares 1,035,396 Est. Cost $36.46 Unrealized +24.9%

PHVS PHARVARIS N V 10.2%

Value ($000) $18,354 Shares 2,278,575 Est. Cost $31.46 Unrealized -72.0%

— IMPEL PHARMACEUTICALS INC 2.1%

Value ($000) $3,864 Shares 2,759,791 Est. Cost $8.85 Unrealized —

— ELEVATION ONCOLOGY INC 2.0%

Value ($000) $3,546 Shares 1,866,339 Est. Cost $13.57 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VTYX	VENTYX BIOSCIENCES INC	2,298,833	$77,011	42.7%	$18.95	+105.2%	COM	92332V107
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$43,844	24.3%	$39.31	-80.7%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	1,035,396	$33,806	18.7%	$36.46	+24.9%	COM	413197104
PHVS	PHARVARIS N V	2,278,575	$18,354	10.2%	$31.46	-72.0%	COM	N69605108
—	IMPEL PHARMACEUTICALS INC	2,759,791	$3,864	2.1%	$8.85	—	COM	45258K109
—	ELEVATION ONCOLOGY INC	1,866,339	$3,546	2.0%	$13.57	—	COM	28623U101